This is a list of stocks that could profit on the swine flu scare.
Our first choice is NanoViricides (NNVC Charts & Stock Quote) which says its Flu-Cide drug is designed to destroy All influenza A viruses including swine and bird Flu.
For more, read Kirk Lindstrom's article:
From All Allan
Our first choice is NanoViricides (NNVC Charts & Stock Quote) which says its Flu-Cide drug is designed to destroy All influenza A viruses including swine and bird Flu.
For more, read Kirk Lindstrom's article:
Swine Flu Cure: NanoViricides Flu-Cide Drug Designed to Destroy Influenza A Viruses
NanoViricides"Flu-Cide" is a cure, not a vaccine. NanoViricides stock did quite well a few years ago during a bird-flu scare when I bought my first shares at $1.01 and took profits at $2.80. See below for long-term chart showing how it surged t0 $3.75 during the 2006 Bird Flu scare. After NNVC came back to Earth after that scare, I started accumulating shares in "Kirk Lindstrom's Investment Letter Explore" (FREE Sample Issue) and personal portfolios to load up for the next run.
From All Allan
Friday's market cap and close:
NNVC $98M.....$0.80
NVAX $98M.....$1.42
SVA $84M......$1.97
AVII $76M.....$0.89
BRCX $85M.....$2.26
7 Top Stocks from StockRake
BCRX, DVAX, GNVC, HEB, INSM, NVAX and SVAFrom OTC Investor
Linkwell Corporation (LWLLE.OB: 0.14 +180.00%) shares moved up more than 250 percent on speculation that demand for disinfectant products could rise in China. The company is the number one producer of disinfectants with 56 product lines in China, but still controls just a fraction of the $6.25 billion market. Investors are betting that the swine flu outbreak will generate demand for disinfectants in China and around the world.
NanoViricides Inc. (NNVC.OB: 1.05 +31.25%) shares jumped more than 40 percent after it re-announced the development of its flu drugs. The company’s FluCide drug has reportedly been effective in targeting two key flu strains in animal testing, but the drug still has yet to go through FDA drug trials in order to be sold commercially. However, investors seem bullish that this drug will reshape the market for flu drugs when it is released.
MultiCell Technologies, Inc. (MCET.OB: 0.0124 +24.00%) shares surged more than 50 percent as investors seemed to recall its past press releases focused on the avian flu. The press release, dated October 21, 2005, announced pre-clinical test results showing positive results for H1N1 flu strains – the same strain as the swine flu. Shareholders are bullish that the company’s toll receptor technology will be able to show similar effectiveness with the swine flu.
Kiwa Bio-Tech Products Group Corporation (KWBTE.OB: 0.0025 +212.50%) shares jumped more than 200 percent as investors recalled its past work with the avian bird flu. A few years ago, the company formed a joint venture to develop Kiwa’s AF-01 anti-viral preventative for avian flu. Investors are bullish on the drugs future prospects, despite the fact that the company only intended to develop it to target animal holding facilities to treat animals.
For commentary and Kirk Lindstrom current outlook for NNVC, read "Kirk's Investment Newsletter"
"Kirk Lindstrom's Investment Letter Explore Portfolio" gained 33.5% in 2009 with 75% in equities and 25% fixed income with an overall portfolio beta of 1.0. For 2009, the DJIA gained 19.2% and Warren Buffett's BRKA only gained 2.4% (FREE Sample Issue)
"Kirk Lindstrom's Investment Letter Explore Portfolio" gained 33.5% in 2009 with 75% in equities and 25% fixed income with an overall portfolio beta of 1.0. For 2009, the DJIA gained 19.2% and Warren Buffett's BRKA only gained 2.4% (FREE Sample Issue)
- NNVC Charts
- FREE Sample Issue of "Kirk Lindstrom's Investment Letter"
NNVC PRICES
| Date | Close $ | Volume |
| 24-Apr-09 | 0.80 | 206,600 |
| 23-Apr-09 | 0.68 | 26,900 |
| 22-Apr-09 | 0.70 | 86,600 |
| 21-Apr-09 | 0.73 | 240,500 |
| 20-Apr-09 | 0.60 | 40,300 |
| 17-Apr-09 | 0.60 | 59,400 |
| 16-Apr-09 | 0.60 | 21,500 |
Since 12/31/98 "Kirk's Explore Portfolio" is UP 159% (a double plus another 59%!!) vs. the S&P500 UP a tiny 8.6% vs. NASDAQ UP a tiny 3.5% (All through
"Kirk Lindstrom's Investment Letter"
HURRY! Subscribe NOW and get the Current Month Issue for FREE! ! (Just mention this advertisement and I will start your 1 year, 12 issue subscription with the next month's issue.)
